表紙:遺伝子編集の世界市場:用途別・技術別・エンドユーザー別の市場規模、産業分析、地域別の展望、成長可能性、競合市場シェア、将来予測 (2022年~2030年)
市場調査レポート
商品コード
1081230

遺伝子編集の世界市場:用途別・技術別・エンドユーザー別の市場規模、産業分析、地域別の展望、成長可能性、競合市場シェア、将来予測 (2022年~2030年)

Gene Editing Market Size by Application, Technology and End-user, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 130 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
遺伝子編集の世界市場:用途別・技術別・エンドユーザー別の市場規模、産業分析、地域別の展望、成長可能性、競合市場シェア、将来予測 (2022年~2030年)
出版日: 2022年05月11日
発行: Global Market Insights Inc.
ページ情報: 英文 130 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子編集の市場規模は、遺伝子合成技術やCRISPR技術の需要拡大により、2030年までに大きく成長すると予測されています。

さらに、研究開発 (R&D) 活動への投資の増加と相まって、技術進歩が今後の市場成長をさらに促進すると考えられています。

用途別に見ると、細胞株工学の分野が予測期間中に15.3%以上のCAGRで拡大すると予定されています。技術別では、CRISPR/Cas9セグメントが2021年に約47%の市場シェアを占め、2030年まで大きく成長すると考えられています。エンドユーザー別では、バイオテクノロジー・製薬企業のセグメントが2021年に24億米ドルを突破し、2030年までかなりの利益を獲得すると推測されています。

当レポートでは、世界の遺伝子編集の市場について分析し、業界の基本構造や求心力、技術・規制環境、主な市場促進・抑制要因、用途別・技術別・エンドユーザー別・地域別の市場動向見通し、主要企業のプロファイル・業績・戦略などを調査しております。

目次

第1章 分析手法

第2章 エグゼクティブサマリー

第3章 遺伝子編集産業の考察

  • 産業区分
  • 産業情勢 (2017年~2030年)
  • 業界への影響要因
    • 成長促進要因
    • 業界の潜在的リスクと課題
  • 成長可能性の分析
  • 新型コロナウイルス感染症 (COVID-19) の影響分析
  • 競合情勢 (2021年)
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 遺伝子編集市場:用途別

  • 主要セグメントの動向
  • 細胞株工学
    • 市場規模:地域別 (単位:100万米ドル、2017年~2030年)
  • 動物遺伝子工学
  • 植物遺伝子工学
  • その他

第5章 遺伝子編集市場:技術別

  • 主要セグメントの動向
  • CRISPR/Cas9
  • ZFN (ジンクフィンガーヌクレアーゼ)
  • TALEN
  • その他

第6章 遺伝子編集市場:エンドユーザー別

  • 主要セグメントの動向
  • バイオテクノロジー・製薬企業
  • CRO (医薬品開発業務受託機関)
  • 研究

第7章 遺伝子編集市場:地域別

  • 地域の主な動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • ポーランド
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 企業プロファイル

  • 戦略ダッシュボード (2021年)
  • Horizon Discovery Ltd.
  • Sangamo Therapeutics, Inc.
  • GeneScript
  • Integrated DNA Technologies, Inc.
  • Precision Biosciences
  • Beam Therapeutics
  • Thermo Fisher Scientific
  • Intellia Therapeutics, Inc.
  • CRISPR Therapeutics
  • Caribou Biosciences, Inc.
図表

Data Tables

  • TABLE 1 Gene editing industry 360 degree synopsis, 2017 - 2030
  • TABLE 2 Global gene editing market size, 2017 - 2021 (USD Million)
  • TABLE 3 Global gene editing market size, 2022 - 2030 (USD Million)
  • TABLE 4 Gene editing market size, by application, 2017 - 2021 (USD Million)
  • TABLE 5 Gene editing market size, by application, 2022 - 2030 (USD Million)
  • TABLE 6 Gene editing market size, by technology, 2017 - 2021 (USD Million)
  • TABLE 7 Gene editing market size, by technology, 2022 - 2030 (USD Million)
  • TABLE 8 Gene editing market size, by end-user, 2017 - 2021 (USD Million)
  • TABLE 9 Gene editing market size, by end-user, 2022 - 2030 (USD Million)
  • TABLE 10 Gene editing market size, by region, 2017 - 2021 (USD Million)
  • TABLE 11 Gene editing market size, by region, 2022 - 2030 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Cell line engineering market size, by region, 2017 - 2030 (USD Million)
  • TABLE 14 Animal genetic engineering market size, by region, 2017 - 2030 (USD Million)
  • TABLE 15 Plant genetic engineering market size, by region, 2017 - 2030 (USD Million)
  • TABLE 16 Others market size, by region, 2017 - 2030 (USD Million)
  • TABLE 17 CRISPR/Cas9 market size, by region, 2017 - 2030 (USD Million)
  • TABLE 18 Zinc Finger Nucleases (ZFNs) market size, by region, 2017 - 2030 (USD Million)
  • TABLE 19 TALENs market size, by region, 2017 - 2030 (USD Million)
  • TABLE 20 Others market size, by region, 2017 - 2030 (USD Million)
  • TABLE 21 Biotech and pharma companies market size, by region, 2017 - 2030 (USD Million)
  • TABLE 22 Contract research organizations (CROs) market size, by region, 2017 - 2030 (USD Million)
  • TABLE 23 Research institutes market size, by region, 2017 - 2030 (USD Million)
  • TABLE 24 North America gene editing market size, by country, 2017 - 2030 (USD Million)
  • TABLE 25 North America gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 26 North America gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 27 North America gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 28 U.S. gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 29 U.S. gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 30 U.S. gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 31 Canada gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 32 Canada gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 33 Canada gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 34 Europe gene editing market size, by country, 2017 - 2030 (USD Million)
  • TABLE 35 Europe gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 36 Europe gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 37 Europe gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 38 UK gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 39 UK gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 40 UK gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 41 Germany gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 42 Germany gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 43 Germany gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 44 France gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 45 France gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 46 France gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 47 Spain gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 48 Spain gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 49 Spain gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 50 Russia gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 51 Russia gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 52 Russia gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 53 Italy gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 54 Italy gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 55 Italy gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 56 Poland gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 57 Poland gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 58 Poland gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 59 Asia Pacific gene editing market size, by country, 2017 - 2030 (USD Million)
  • TABLE 60 Asia Pacific gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 61 Asia Pacific gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 62 Asia Pacific gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 63 China gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 64 China gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 65 China gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 66 Japan gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 67 Japan gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 68 Japan gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 69 India gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 70 India gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 71 India gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 72 Australia gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 73 Australia gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 74 Australia gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 75 South Korea gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 76 South Korea gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 77 South Korea gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 78 Latin America gene editing market size, by country, 2017 - 2030 (USD Million)
  • TABLE 79 Latin America gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 80 Latin America gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 81 Latin America gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 82 Argentina gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 83 Argentina gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 84 Argentina gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 85 Brazil gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 86 Brazil gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 87 Brazil gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 88 Mexico gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 89 Mexico gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 90 Mexico gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 91 MEA gene editing market size, by country, 2017 - 2030 (USD Million)
  • TABLE 92 MEA gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 93 MEA gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 94 MEA gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 95 South Africa gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 96 South Africa gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 97 South Africa gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 98 Saudi Arabia gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 99 Saudi Arabia gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 100 Saudi Arabia gene editing market size, by end-user, 2017 - 2030 (USD Million)
  • TABLE 101 UAE gene editing market size, by application, 2017 - 2030 (USD Million)
  • TABLE 102 UAE gene editing market size, by technology, 2017 - 2030 (USD Million)
  • TABLE 103 UAE gene editing market size, by end-user, 2017 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Market estimation and forecast methodology
  • FIG. 2 Gene editing industry 36 degree synopsis
  • FIG. 3 Industry segmentation
  • FIG. 4 Global gene editing market size, 2017 - 2030 (USD Million)
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by technology
  • FIG. 7 Growth potential analysis, by end-user
  • FIG. 8 Strategy dashboard, 2021
  • FIG. 9 Porter's analysis
  • FIG. 10 PESTLE analysis
  • FIG. 11 Key segment trends, by application
  • FIG. 12 Key segment trends, by technology
  • FIG. 13 Key segment trends, by end-user
  • FIG. 14 Key segment trends, by region
目次
Product Code: 810

The gene editing market is projected to grow massively by 2030 owing to rising demand for gene synthesis and CRISPR technologies. In addition, technological advancements, coupled with growing investment in R&D activities, are speculated to further propel market growth through the forecast timespan.

Recently, the COVID-19 pandemic has impacted the market positively as gene editing technologies allow the detection of SARS-CoV-2 and the alteration of defected genes in plants and animals. Prominent technological advancements in the market have positively influenced the overall product landscape.

Recently, in May 2022, a Nature Nanotechnology study aimed to enhance CRISPR/Cas9 gene editing by modulating cellular mechanical properties for the treatment of cancer. It concluded that modulating the stiffness of the tumor tissue can help in improving gene editing in tumors, offering a new strategy for cancer treatment with gene editing.

Moreover, government initiatives to encourage research and development activities for the treatment of genetic disorders have fueled gene editing market growth. For instance, in May 2022, the U.S. Food and Drug Administration (FDA) awarded fast-track designation to biotech firm Graphite Bio's GPH101, a gene editing therapy that has been developed to correct genetic mutation caused by sickle cell disease.

Furthermore, key participants in the industry have been focusing on technological innovation in gene editing therapies, along with effective growth strategies, to prosper in the market. To quote an instance, in May 2022, U.S. FDA granted Orphan Drug Designation to EDIT-301, an experimental gene editing therapy by clinical-stage biotech company Editas Medicine to treat beta thalassemia.

The gene editing market has been bifurcated based on end-user, application, technology, and region. In terms of application, the market has been categorized into animal genetic engineering, plant genetic engineering, cell line engineering, and others. The cell line engineering segment is slated to expand at a CAGR of more than 15.3% through the forecast period due to the widespread application of cell line engineering.

With reference to technology, the gene editing industry has been divided into zinc finger nucleases (ZFNs), TALENs, CRISPR/Cas9, and others. The CRISPR/Cas9 segment held around 47% market share in 2021 and is set to grow prominently up to 2030 owing to the rise in CRISPR technology preference due to its several benefits.

With regards to end-user, the market has been segregated into contract research organizations (CROs), research institutes, and biotech and pharma companies. The biotech and pharma companies segment surpassed $2.4 billion valuation in 2021 and is speculated to register substantial gains through 2030. Increasing focus of biopharmaceutical companies on developing advanced gene editing technologies is likely to fuel segmental growth over the review timespan.

In the regional frame of reference, the Latin America gene editing market accounted for over 11.1% of the overall industry revenue in 2021. This growth is attributed to mounting incidences of genetic disorders across several countries in the LATAM region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Base estimates & working
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Gene editing industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Application trends
    • 2.1.3 Technology trends
    • 2.1.4 End-user trends
    • 2.1.5 Regional trends

Chapter 3 Gene Editing Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increased funding for genetic research in North America
      • 3.3.1.2 Rising R&D expenditure and growth of biotechnology in Europe
      • 3.3.1.3 Increasing demand for synthetic genes in Asia Pacific and North America
      • 3.3.1.4 Technology advancements in gene editing in North America
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Stringent government regulations
      • 3.3.2.2 Lack of public awareness in underdeveloped economies
  • 3.4 Growth potential analysis
    • 3.4.1 By application
    • 3.4.2 By technology
    • 3.4.3 By end-user
  • 3.5 COVID-19 impact analysis
  • 3.6 Competitive landscape, 2021
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Gene Editing Market, By Application

  • 4.1 Key segment trends
  • 4.2 Cell line engineering
    • 4.2.1 Market size, by region, 2017-2030 (USD Million)
  • 4.3 Animal genetic engineering
    • 4.3.1 Market size, by region, 2017-2030 (USD Million)
  • 4.4 Plant genetic engineering
    • 4.4.1 Market size, by region, 2017-2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Market size, by region, 2017-2030 (USD Million)

Chapter 5 Gene Editing Market, By Technology

  • 5.1 Key segment trends
  • 5.2 CRISPR/Cas9
    • 5.2.1 Market size, by region, 2017-2030 (USD Million)
  • 5.3 Zinc Finger Nucleases (ZFNs)
    • 5.3.1 Market size, by region, 2017-2030 (USD Million)
  • 5.4 TALENs
    • 5.4.1 Market size, by region, 2017-2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017-2030 (USD Million)

Chapter 6 Gene Editing Market, By End-user

  • 6.1 Key segment trends
  • 6.2 Biotech and pharma companies
    • 6.2.1 Market size, by region, 2017-2030 (USD Million)
  • 6.3 Contract research organizations (CROs)
    • 6.3.1 Market size, by region, 2017-2030 (USD Million)
  • 6.4 Research institutes
    • 6.4.1 Market size, by region, 2017-2030 (USD Million)

Chapter 7 Gene Editing Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017-2030 (USD Million)
    • 7.2.2 Market size, by application, 2017-2030 (USD Million)
    • 7.2.3 Market size, by technology, 2017-2030 (USD Million)
    • 7.2.4 Market size, by end-user, 2017-2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by application, 2017-2030 (USD Million)
      • 7.2.5.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.2.5.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by application, 2017-2030 (USD Million)
      • 7.2.6.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.2.6.3 Market size, by end-user, 2017-2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017-2030 (USD Million)
    • 7.3.2 Market size, by application, 2017-2030 (USD Million)
    • 7.3.3 Market size, by technology, 2017-2030 (USD Million)
    • 7.3.4 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.5.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.5.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.6.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.6.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.7.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.7.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.8.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.8.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.9.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.9.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.10 Russia
      • 7.3.10.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.10.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.10.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.3.11 Poland
      • 7.3.11.1 Market size, by application, 2017-2030 (USD Million)
      • 7.3.11.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.3.11.3 Market size, by end-user, 2017-2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017-2030 (USD Million)
    • 7.4.2 Market size, by application, 2017-2030 (USD Million)
    • 7.4.3 Market size, by technology, 2017-2030 (USD Million)
    • 7.4.4 Market size, by end-user, 2017-2030 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size, by application, 2017-2030 (USD Million)
      • 7.4.5.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.4.5.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.4.6 China
      • 7.4.6.1 Market size, by application, 2017-2030 (USD Million)
      • 7.4.6.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.4.6.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by application, 2017-2030 (USD Million)
      • 7.4.7.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.4.7.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by application, 2017-2030 (USD Million)
      • 7.4.8.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.4.8.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by application, 2017-2030 (USD Million)
      • 7.4.9.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.4.9.3 Market size, by end-user, 2017-2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017-2030 (USD Million)
    • 7.5.2 Market size, by application, 2017-2030 (USD Million)
    • 7.5.3 Market size, by technology, 2017-2030 (USD Million)
    • 7.5.4 Market size, by end-user, 2017-2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by application, 2017-2030 (USD Million)
      • 7.5.5.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.5.5.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by application, 2017-2030 (USD Million)
      • 7.5.6.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.5.6.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by application, 2017-2030 (USD Million)
      • 7.5.7.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.5.7.3 Market size, by end-user, 2017-2030 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2017-2030 (USD Million)
    • 7.6.2 Market size, by application, 2017-2030 (USD Million)
    • 7.6.3 Market size, by technology, 2017-2030 (USD Million)
    • 7.6.4 Market size, by end-user, 2017-2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by application, 2017-2030 (USD Million)
      • 7.6.5.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.6.5.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by application, 2017-2030 (USD Million)
      • 7.6.6.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.6.6.3 Market size, by end-user, 2017-2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by application, 2017-2030 (USD Million)
      • 7.6.7.2 Market size, by technology, 2017-2030 (USD Million)
      • 7.6.7.3 Market size, by end-user, 2017-2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2021
  • 8.2 Horizon Discovery Ltd.
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Sangamo Therapeutics, Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 GeneScript
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Integrated DNA Technologies, Inc.
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Precision Biosciences
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Beam Therapeutics
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Thermo Fisher Scientific
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Intellia Therapeutics, Inc.
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 CRISPR Therapeutics
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Caribou Biosciences, Inc.
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis